Concepedia

I’ah Donovan-Banfield

ID

Statistics

Publications

12

Citations

622

H-Index

11

Active since

2016

Affiliations

University of Liverpool(Current)

Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool

Agency for Science, Technology and Research

University of Oxford

University of Bristol

I’ah Donovan-Banfield is an author at University of Liverpool specializing in life sciences, virology, and molecular virology.

Publications per year

2016–2023

12

Publications

12

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

Theo Sanderson, Ryan Hisner, I’ah Donovan-Banfield et al. · Nature · 2023 · 201 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders et al. · The Lancet Infectious Diseases · 2022 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway

Jie Zhou, Thomas P. Peacock, Jonathan C. Brown et al. · Cell Reports · 2022 · 71 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +13

Deep splicing plasticity of the human adenovirus type 5 transcriptome drives virus evolution

I’ah Donovan-Banfield, Andrew S. Turnell, Julian A. Hiscox et al. · Communications Biology · 2020 · 65 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

I’ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain et al. · Nature Communications · 2022 · 42 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

1–5 of 12